AHFS Drug Informationauthority of the Board of Directors of the American Society of Hospital Pharmacists, 1990 - Drugs |
From inside the book
Results 1-3 of 92
Page 40
... single dose on the first day , followed by 1 g daily given as single daily doses for 6 days . Children . For the treatment of cestodiasis caused by H. nana in children weighing more than 34 kg , the usual initial dosage of niclosamide ...
... single dose on the first day , followed by 1 g daily given as single daily doses for 6 days . Children . For the treatment of cestodiasis caused by H. nana in children weighing more than 34 kg , the usual initial dosage of niclosamide ...
Page 127
... single 500 - mg dose of the drug and 10-11.4 L following a single 2 - g dose . The volume of distribution of ceftriaxone is 0.497-0.608 L / kg in neonates 1-45 days of age and 0.26-0.54 Lkg in children 1.5 months to 16 years of age ...
... single 500 - mg dose of the drug and 10-11.4 L following a single 2 - g dose . The volume of distribution of ceftriaxone is 0.497-0.608 L / kg in neonates 1-45 days of age and 0.26-0.54 Lkg in children 1.5 months to 16 years of age ...
Page 273
... single 2 - g dose , and 1.05 hours after a single 6 - g dose . The tip of mezlocillin reportedly averages 0.96 hours after a single 1 - g dose of the drug and 1.2 hours after a single 5 - g dose . Although there is little published ...
... single 2 - g dose , and 1.05 hours after a single 6 - g dose . The tip of mezlocillin reportedly averages 0.96 hours after a single 1 - g dose of the drug and 1.2 hours after a single 5 - g dose . Although there is little published ...
Other editions - View all
Common terms and phrases
acid active active in vitro acute addition administration adults adverse agents alcohol aminoglycoside aminopenicillins amphotericin ampicillin and/or anti-infective antibiotics antihistamines appears approximately associated averaged aztreonam bacteria caused by susceptible Cautions cefoperazone cefotaxime ceftazidime ceftriaxone cefuroxime cephalosporins Chemistry chloride clavulanate clinical clinicians combination commercially available considered containing creatinine currently daily dextrose disease distributed dosage dose drug effects erythromycin evidence excreted given gonorrhoeae gram-negative greater half-life hydrochloride hypersensitivity imipenem impairment increased indicate infections caused infusion inhibited initial less manufacturer meningitis mg/kg mg/mL minutes moxalactam neonates occur oral organisms parenteral patients receiving peak penicillin penicillinase-resistant potassium potential Preparations prophylaxis ranged reactions recommend reconstituted regimen renal function reported reportedly resistant respectively serum concentrations severe single skin sodium solutions Stability Statement sterile strains streptococci studies suggest tablets temperature therapy tion tract treatment units urine usual vitro weeks µg/mL